SAFETYNADOL Trademark

Trademark Overview

On Monday, December 6, 2021, a trademark application was filed for SAFETYNADOL with the United States Patent and Trademark Office. The USPTO has given the SAFETYNADOL trademark a serial number of 97157154. The federal status of this trademark filing is STATEMENT OF USE - TO EXAMINER as of Saturday, December 13, 2025. This trademark is owned by SINEW PHARMA INC.. The SAFETYNADOL trademark is filed in the Pharmaceutical Products category with the following description:

Analgesics; Anti-inflammatory preparations; Anti-inflammatory and antipyretic preparations; Medicines for antipyretic therapy
safetynadol

General Information

Serial Number97157154
Word MarkSAFETYNADOL
Filing DateMonday, December 6, 2021
Status748 - STATEMENT OF USE - TO EXAMINER
Status DateSaturday, December 13, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 18, 2022

Trademark Statements

Goods and ServicesAnalgesics; Anti-inflammatory preparations; Anti-inflammatory and antipyretic preparations; Medicines for antipyretic therapy

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 10, 2021
Primary Code005
First Use Anywhere DateThursday, January 21, 2021
First Use In Commerce DateSaturday, December 31, 2022

Trademark Owner History

Party NameSINEW PHARMA INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTaipei City 11571
TW
Party NameSINEW PHARMA INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTaipei City 11571
TW

Trademark Events

Event DateEvent Description
Thursday, December 9, 2021NEW APPLICATION ENTERED
Friday, December 10, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 14, 2022ASSIGNED TO EXAMINER
Wednesday, September 14, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 28, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 18, 2022PUBLISHED FOR OPPOSITION
Tuesday, October 18, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 13, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, April 21, 2023SOU TEAS EXTENSION RECEIVED
Friday, April 21, 2023SOU EXTENSION 1 FILED
Friday, April 21, 2023SOU EXTENSION 1 GRANTED
Tuesday, April 25, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 24, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, October 24, 2023SOU EXTENSION 2 FILED
Tuesday, October 24, 2023SOU EXTENSION 2 GRANTED
Friday, October 27, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 23, 2024SOU TEAS EXTENSION RECEIVED
Thursday, May 23, 2024SOU EXTENSION 3 FILED
Thursday, May 23, 2024SOU EXTENSION 3 GRANTED
Friday, May 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 28, 2024SOU TEAS EXTENSION RECEIVED
Thursday, November 28, 2024SOU EXTENSION 4 FILED
Thursday, November 28, 2024SOU EXTENSION 4 GRANTED
Monday, March 3, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 19, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, June 4, 2025ASSIGNED TO EXAMINER
Wednesday, June 4, 2025ASSIGNED TO EXAMINER
Thursday, October 2, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sunday, May 18, 2025SOU EXTENSION 5 FILED
Thursday, October 2, 2025SOU EXTENSION 5 GRANTED
Friday, October 3, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 11, 2025TEAS STATEMENT OF USE RECEIVED
Thursday, December 11, 2025USE AMENDMENT FILED
Saturday, December 13, 2025STATEMENT OF USE PROCESSING COMPLETE

Related Keywords

safetynadol antipyretic inflammatory preparations anti therapy medicines analgesics